Insider Trading Alert - MMS, APO, TRS, XOM And DLPH Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 17, 2013, 129 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $69.90 to $563,062,500.00.

Highlighted Stocks Traded by Insiders:

Maximus (MMS) - FREE Research Report

Andrekovich Mark who is Chief of Human Capital at Maximus sold 2,705 shares at $43.62 on Dec. 17, 2013. Following this transaction, the Chief of Human Capital owned 50,036 shares meaning that the stake was reduced by 5.13% with the 2,705-share transaction.

The shares most recently traded at $43.12, down $0.50, or 1.16% since the insider transaction. Historical insider transactions for Maximus go as follows:

  • 4-Week # shares sold: 7,898
  • 12-Week # shares sold: 47,493
  • 24-Week # shares sold: 47,493

The average volume for Maximus has been 396,600 shares per day over the past 30 days. Maximus has a market cap of $3.0 billion and is part of the services sector and diversified services industry. Shares are up 36.57% year-to-date as of the close of trading on Tuesday.

MAXIMUS, Inc. provides business process services to government health and human services agencies in the United States, Australia, Canada, the United Kingdom, and Saudi Arabia. The company operates in two segments, Health Services and Human Services. The stock currently has a dividend yield of 0.41%. The company has a P/E ratio of 26.0. Currently there are 5 analysts that rate Maximus a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MMS - FREE

TheStreet Quant Ratings rates Maximus as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Maximus Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

Maximus Should Benefit From Outsourcing of Health Benefits Work

Insider Trading Alert - AOSL, MMS And STT Traded By Insiders

Insider Trading Alert - OPHT, MMS And MLNX Traded By Insiders

Insider Trading Alert - ALG, MMS And EBAY Traded By Insiders

Analysts' Actions -- J.C. Penney, Pfizer, Steel Dynamics, Valspar and More